Cargando…
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
BACKGROUND AND OBJECTIVES: The identification of predictors of response to antiCGRP mAbs could favor tailored therapies and personalized treatment plans. This study is aimed at investigating predictors of ≥ 50%, ≥ 75% and 100% response at 24 weeks in patients with high-frequency episodic (HFEM: 8–14...
Autores principales: | Barbanti, Piero, Egeo, Gabriella, Aurilia, Cinzia, Altamura, Claudia, d’Onofrio, Florindo, Finocchi, Cinzia, Albanese, Maria, Aguggia, Marco, Rao, Renata, Zucco, Maurizio, Frediani, Fabio, Filippi, Massimo, Messina, Roberta, Cevoli, Sabina, Carnevale, Antonio, Fiorentini, Giulia, Messina, Stefano, Bono, Francesco, Torelli, Paola, Proietti, Stefania, Bonassi, Stefano, Vernieri, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623966/ https://www.ncbi.nlm.nih.gov/pubmed/36316648 http://dx.doi.org/10.1186/s10194-022-01498-6 |
Ejemplares similares
-
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
por: Barbanti, Piero, et al.
Publicado: (2022) -
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
por: Barbanti, Piero, et al.
Publicado: (2022) -
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
por: Barbanti, Piero, et al.
Publicado: (2022) -
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study
por: Barbanti, Piero, et al.
Publicado: (2023) -
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study
por: Altamura, Claudia, et al.
Publicado: (2020)